Fifth Street Asset Management Inc. Schedules Earnings Release for the Quarter Ended March 31, 2016
Apr 15, 2016 11:34 am UTC| Business
GREENWICH, CT, April 15, 2016 -- Fifth Street Asset Management Inc. (NASDAQ:FSAM) (“FSAM”) announced today that it plans to report earnings for the quarter and year ended March 31, 2016, after the financial markets...
Apr 15, 2016 11:32 am UTC| Business
GREENWICH, CT, April 15, 2016 -- Fifth Street Senior Floating Rate Corp. (NASDAQ:FSFR) (“FSFR”) today announced that it plans to report earnings for the period ended March 31, 2016 after the financial markets close in...
Neonode Signs Distribution Agreement for AirBar™ Devices With Ingram Micro® U.S.A
Apr 15, 2016 11:31 am UTC| Business
STOCKHOLM, Sweden, April 15, 2016 -- Neonode Inc. (NASDAQ:NEON), the Optical Interactive Sensing Technology Company, has signed a distribution agreement with Ingram Micro Inc. (NYSE:IM) for the distribution of AirBar...
Apr 15, 2016 11:30 am UTC| Business
RADNOR, Pa., April 15, 2016 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today...
Conatus Poster at EASL Meeting Today Addresses Safety of Caspase Inhibition in Cancer Treatment
Apr 15, 2016 11:30 am UTC| Business
SAN DIEGO, April 15, 2016 -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) announced that a poster addressing results in both ex vivo cell culture and in vivo mouse models of hepatocellular carcinoma with IDN-7314, an...
Apr 15, 2016 11:30 am UTC| Business
HOUSTON, April 15, 2016 -- LINN Energy, LLC (“LINN” or "Company") (NASDAQ:LINE) and LinnCo, LLC (NASDAQ:LNCO) announced that LINN and Berry Petroleum Company, LLC (“Berry”) made interest payments on April 14, 2016 of...
Carbylan Therapeutics Announces Decision to Pursue Strategic Transaction
Apr 15, 2016 11:30 am UTC| Business
PALO ALTO, Calif., April 15, 2016 -- Carbylan Therapeutics (NASDAQ:CBYL), a specialty pharmaceutical company, announced today that it has suspended further clinical development of Hydros-TA and that it is actively...